You are here > News and publications

News and publications

Eric Halioua was appointed CEO

01/06/2009

 

Louvain-le-Neuve (Belgium) June 2009 – Promethera Biosciences, a new company active in
the field of regenerative medicine for the treatment of liver diseases was created in February
2009 and recently appointed a new Chief Executive Officer, Eric Halioua, to perform capital
increase and develop the company.

 

Louvain-le-Neuve (Belgium) June 2009 – Promethera Biosciences, a new company active in the field of regenerative medicine for the treatment of liver diseases was created in February 2009 and appointed the Chief Executive Officer, Eric Halioua, to perform capital increase and develop the Company.

 

 

Dowload this file

 

Contacts

PROMETHERA Biosciences S.A./N.V.
Watson & Crick Hill
Rue Granbonpré, 11
B-1435 Mont-Saint-Guibert
(Belgium)
Tél.: +32 (0)10 39 43 00
Fax: +32 (0)10 39 43 01

News and Public release

CEO John Tchelingerian to Discuss Strategic Collobarations and Partnering Strategies in Cell Therapy at ARM’s Advanced Therapies Summit
Collaboration to Drive Development and Commercialization of Promethera’s Cell-based Liver-Focused Therapeutics Portfolio in Korea